Paper Review Records
All Paper Review Records
5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
27
days
Generation of Induced Pluripotent Stem Cell Line FAMRCi016-A from a Patient with Restrictive Cardiomyopathy Carrying the Genetic Variant FLNC : c.3557C>T p.(Ala1186Val)
AuthorsE. G. Nikitina; A. A. Khudiakov; K. I. Perepelina; N. L. Rodina; Yu. V. Fomicheva; M. Yu. Sharikova; K. A. Lavrenteva; E. A. Zerkalenkova; D. V. Goliusova; A. M. Zlotina; A. A. Kostareva
Affiliations1. Almazov National Medical Research Center, Saint-Petersburg, Russia; 2. Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine, Moscow, Russia; 3. Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia; 4. Pirogov Russian National Research Medical University, Moscow, Russia; 5. Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Moscow, Russia
48
days
Derivation of Induced Pluripotent Stem Cell Lines RCPCMi016-A and RCPCMi016-B by Reprogramming Dermal Fibroblasts from a Patient with Spinocerebellar Ataxia Type 27B
AuthorsA. V. Spaselnikova; E. A. Balezina; M. Yu. Sharikova; E. A. Volovikov; T. V. Limanskaya; V. V. Nenasheva; E. A. Stepanenko; T. P. Gerasimova; E. V. Novosadova; M. E. Bogomyakova; E. A. Zerkalenkova; E. P. Nuzhnyi; A. N. Bogomazova; O. S. Lebedeva; M. A. Lagarkova; S. N. Illarioshkin
Affiliations1. Lopukhin Federal Scientific and Clinical Center for Physical-Chemical Medicine of the Federal Medical Biological Agency, Moscow, Russia; 2. Moscow State University, Moscow, Russia; 3. Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia; 4. Pirogov Russian National Research Medical University (RNRMU), Moscow, Russia; 5. Russian Сenter of Neurology and Neurosciences, Moscow, Russia
53
days
Generation of the RCPCMi015-A Induced Pluripotent Stem Cell Line by Reprogramming of Dermal Fibroblasts from a Patient with Developmental and Epileptic Encephalopathy-17 Carrying the GNAO1 c.155A>G ( p.Q52R ) Genetic Variant
AuthorsE. A. Volovikov; T. V. Limanskaya; E. A. Zerkalenkova; A. A. Abramov; D. N. Silachev; A. N. Bogomazova; V. L. Katanaev; M. A. Lagarkova
Affiliations1. Lopukhin Federal Research and Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency, Moscow, Russia; 2. Dmitry Rogachev National Medical Research Center of Pediatric Hematology, Oncology and Immunology, Moscow, Russia; 3. Pirogov Russian National Research Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia; 4. Voyno-Yasenetsky Scientific and Practical Center of Specialized Medical Care for Children, Moscow, Russia; 5. Department of Cell Physiology and Metabolism, Translational Research Centre in Oncohaematology, Faculty of Medicine, University of Geneva, Geneva, Switzerland; 6. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of the Russian Federation, Moscow, Russia
65
days
Towards Scarless Healing: Approaches to Stimulating Scarless Regeneration of Human Skin Using a Xenotransplantation Model
AuthorsO. L. Cherkashina; D. S. Abolin; O. S. Rogovaya; E. I. Morgun; M. S. Shitova; T. V. Noskova; E. A. Vorotelyak; E. P. Kalabusheva
Affiliations1. Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Moscow, Russia; 2. Department of Cell Biology and Histology, Faculty of Biology, Moscow State University, Moscow, Russia
223
days
Notch Signaling Pathway as an Intermediate in DIO2-Mediated Regulation of Cellular Heterogeneity in the Mouse Endometrial Stroma
AuthorsA. O. Gaidamaka; Ya. S. Tatarenko; A. D. Aleksandrova; E. A. Chikina; S. M. Rumiantseva; E. A. Vorotelyak
Affiliations1. Koltzov Institute of Developmental Biology of the Russian Academy of Sciences, Moscow, Russia; 2. LLC LIFT Center, Moscow, Russia; 3. Faculty of Biology, Moscow State University, Moscow, Russia
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days